(Q45084106)

English

Clinical trials with Dismutec (pegorgotein; polyethylene glycol-conjugated superoxide dismutase; PEG-SOD) in the treatment of severe closed head injury

scientific article published in January 1994

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

9 December 2017

Clinical trials with Dismutec (pegorgotein; polyethylene glycol-conjugated superoxide dismutase; PEG-SOD) in the treatment of severe closed head injury (English)

1 reference

stated in

Europe PubMed Central

9 December 2017

J P Muizelaar

1

1 reference

stated in

Europe PubMed Central

PubMed ID

7771267

retrieved

9 December 2017

language of work or name

English

0 references

publication date

1 January 1994

1 reference

stated in

Europe PubMed Central

9 December 2017

Advances in Experimental Medicine and Biology

1 reference

stated in

Europe PubMed Central

9 December 2017

366

1 reference

stated in

Europe PubMed Central

9 December 2017

389-400

1 reference

stated in

Europe PubMed Central

PubMed ID

7771267

retrieved

9 December 2017

Identifiers

DOI

10.1007/978-1-4615-1833-4_27

0 references

PubMed ID

7771267

1 reference

stated in

Europe PubMed Central

PubMed ID

7771267

retrieved

9 December 2017

(Q45084106)

Clinical trials with Dismutec (pegorgotein; polyethylene glycol-conjugated superoxide dismutase; PEG-SOD) in the treatment of severe closed head injury

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)